The MURDOCK Study Registry and Biorepository Horizon 1.5 (MURDOCK)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01708408 |
Recruitment Status
:
Recruiting
First Posted
: October 17, 2012
Last Update Posted
: February 12, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Chronic Disease Healthy Volunteers | Genetic: Biomarker studies |
Study Type : | Observational |
Estimated Enrollment : | 50000 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Official Title: | Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis The MURDOCK Study Registry and Biorepository Horizon 1.5 |
Study Start Date : | February 2009 |
Estimated Primary Completion Date : | December 2020 |
Estimated Study Completion Date : | December 2020 |
Group/Cohort | Intervention/treatment |
---|---|
community | Genetic: Biomarker studies |
- The MURDOCK Study Registry and Biorepository Horizon 1.5 [ Time Frame: Upto 119 months ]To provide information for large-scale epidemiologic and clinical translational research and the research infrastructure to identify specific phenotypes and outcomes to improve medicine
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- A resident of Cabarrus County and/or the city of Kannapolis (and surrounding regions) for 6 or more months of the year
- At least 18 years of age
- Able to understand and give written informed consent, or have a legal guardian or caregiver present to give informed consent by proxy (assent from a participant between ages 12-18 will be obtained when their parent or legal guardian consents on their behalf).
- Willing and able to participate in all 5 components of the registry and biorepository as described above in Section III
Exclusion Criteria:
1. There are no exclusions to participation if all inclusion criteria have been met.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01708408
Contact: Leah Bouk | 704-250-5856 | leah.bouk@duke.edu | |
Contact: Perla Nunes | 704-250-5858 | perla.nunes@duke.edu |
United States, North Carolina | |
Duke Translational Medicine Institute-MURDOCK Study | Recruiting |
Kannapolis, North Carolina, United States, 28081 | |
Contact: Leah Bouk 704-250-5861 leah.bouk@duke.edu | |
Contact: Perla Nunes 704-250-5858 perla.nunes@duke.edu | |
Principal Investigator: L. Kristin Newby, MD, MHS |
Principal Investigator: | Kristin M Newby, MD | Duke University |
Additional Information:
Publications:
Responsible Party: | Duke University |
ClinicalTrials.gov Identifier: | NCT01708408 History of Changes |
Other Study ID Numbers: |
Pro00011196 |
First Posted: | October 17, 2012 Key Record Dates |
Last Update Posted: | February 12, 2018 |
Last Verified: | February 2018 |
Keywords provided by Duke University:
biorepository biobank registry community biospecimens volunteers |
chronic disease longitudinal blood electronic health records follow-up |
Additional relevant MeSH terms:
Chronic Disease Disease Attributes Pathologic Processes |